Trade Biogaia B - BIOGb CFD
Add to favourite- Summary
- Historical Data
Spread | 2.3 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.021243% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.000979% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | SEK | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | Sweden | ||||||||
Commission on trade | 0% |
Prev. Close | 123.4 |
Open | 120.5 |
1-Year Change | 17.1% |
Day's Range | 120.5 - 126.7 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jul 25, 2024 | 123.4 | -1.9 | -1.52% | 125.3 | 126.0 | 122.3 |
Jul 24, 2024 | 126.5 | 0.2 | 0.16% | 126.3 | 127.6 | 119.7 |
Jul 23, 2024 | 127.5 | -3.7 | -2.82% | 131.2 | 134.0 | 126.3 |
Jul 22, 2024 | 122.0 | -0.3 | -0.25% | 122.3 | 126.0 | 120.0 |
Jul 19, 2024 | 120.5 | -1.9 | -1.55% | 122.4 | 124.5 | 120.5 |
Jul 18, 2024 | 124.5 | 1.3 | 1.06% | 123.2 | 126.5 | 122.4 |
Jul 17, 2024 | 126.3 | 4.0 | 3.27% | 122.3 | 126.8 | 122.3 |
Jul 16, 2024 | 124.1 | 1.3 | 1.06% | 122.8 | 127.1 | 120.6 |
Jul 15, 2024 | 123.0 | 1.1 | 0.90% | 121.9 | 124.3 | 120.7 |
Jul 12, 2024 | 123.7 | 0.1 | 0.08% | 123.6 | 125.8 | 121.8 |
Jul 11, 2024 | 123.2 | 1.4 | 1.15% | 121.8 | 124.0 | 120.5 |
Jul 10, 2024 | 122.2 | 3.1 | 2.60% | 119.1 | 122.4 | 118.3 |
Jul 9, 2024 | 121.7 | -0.3 | -0.25% | 122.0 | 125.3 | 119.2 |
Jul 8, 2024 | 124.7 | 2.6 | 2.13% | 122.1 | 125.2 | 122.1 |
Jul 5, 2024 | 123.4 | 1.1 | 0.90% | 122.3 | 123.5 | 120.8 |
Jul 4, 2024 | 122.0 | -0.6 | -0.49% | 122.6 | 124.1 | 119.6 |
Jul 3, 2024 | 120.3 | -1.3 | -1.07% | 121.6 | 122.6 | 118.7 |
Jul 2, 2024 | 122.5 | 0.7 | 0.57% | 121.8 | 123.4 | 119.3 |
Jul 1, 2024 | 123.7 | 1.2 | 0.98% | 122.5 | 123.9 | 120.5 |
Jun 28, 2024 | 122.9 | 1.9 | 1.57% | 121.0 | 124.4 | 121.0 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Biogaia Company profile
About BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, BioGaia AB revenues increased 5% to SEK785.1M. Net income increased 9% to SEK196.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Other operating expenses/operating incom decrease from SEK17.4M (expense) to SEK11.2M (income). Dividend per share increased from SEK6.82 to SEK7.26.
Industry: | Biopharmaceuticals |
Kungsbroplan 3
STOCKHOLM
STOCKHOLM 112 27
SE
News
![](https://img.capital.com/imgs/articles/192x130x1/Risk-Management-in-Trading.png)
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ECB_0.png)
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024![](https://img.capital.com/imgs/articles/192x130x1/risk_2_1_optimized_450_1.png)
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024![](https://img.capital.com/imgs/articles/192x130x1/Stock-1-_1.png)
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ETF-1-_0.png)
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024![Lloyds share price forecast: An attractive dividend stock? Lloyds share price forecast: An attractive dividend stock?](https://img.capital.com/imgs/articles/192x130x1/shutterstock_536730610_0.jpg)
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024![](https://img.capital.com/imgs/articles/192x130x1/RBNZ.png)
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com